Big Tech Dominance: 5 Companies Projected To Lap Average S&P 500 Stock’s Earnings Growth
SPY ETF Trust's performance exceeds average return in 6 months, largely due to gains by big tech companies like MSFT, NVDA, AMZN, GOOG, and META.
Industry Groups Back GSK’s Effort To Halt 70,000 Lawsuits Associated With Heartburn Drug Zantac Caused Cancer
GSK, supported by major industry groups, seeks to stop 70,000 Zantac lawsuits in Delaware, arguing a recent court ruling threatens the state's business-friendly reputation and judicial consistency.
Johnson & Johnson Faces New Lawsuit(s) Related To Its Talc Products
Johnson & Johnson faces a new class action lawsuit seeking damages and medical monitoring for cancer risk from talc products.
German Drug Developer Evotec Seeks Adviser Input As Takeover Concerns Mount
Evotec consults defense advisers following a significant share price decline, raising concerns about a potential takeover.
S&P 500, Nasdaq 100 Dip From Record Highs As Investors Take Chipmaker Profits; Energy Sector Rebounds, Yields Rise: What’s Driving Markets Thursday?
After the Juneteenth holiday break, Wall Street reopened with a cautious tone, as the S&P 500 and Nasdaq 100 indices declined after hitting all-time highs around midday trading in New York. This decline was driven by profit-taking in chipmaker stocks and rising Treasury yields, which dampened risk sentiment.
Kroger To Gain Traction From Households And Traffic Growth – Analyst Bullish On Future Sales
Kroger Company's strong Q1 earnings beat and growth in digital sales set a positive trajectory amid bullish analyst outlooks on future sales and profitability.
Darden Stumbles on Sales, But Analysts Stay Optimistic On Operational Execution: Here’s Why
Analysts reiterate ratings and price targets for Darden Restaurants (DRI) following Q4 earnings release. EPS beats, sales miss expectations.
Salesforce Integrates AI Tools, Investors Watch for Revenue Impact: Bloomberg
Salesforce integrates AI tools, but struggling to monetize them. Stock gained 11% in last 12 months. India division launched for growing market.
Johnson & Johnson’s Arthritis Drug Shows Potential In Crohn’s Disease
Johnson & Johnson announced that their Phase 3 GRAVITI study of Tremfya (guselkumab) SC therapy for Crohn's disease met all primary and secondary endpoints.
TotalEnergies Lights Up Nigeria’s Future With Ubeta Gas Field FID
TotalEnergies and NNPCL have made FID for Ubeta gas field in Nigeria. Production starts in 2027, with gas supplying domestic market and Nigeria LNG.